Hormone Therapy Centers of America

What Hormone Therapy Centers of America does

Hormone Therapy Centers of America (HTCA) is a Plano, Texas-based private healthcare services company that operates under the Purepell brand and runs a national network of Certified Purepell Providers. The company's core offering is bioidentical hormone replacement therapy (BHRT) delivered through subcutaneous hormone pellets, which release bioidentical hormones continuously 24/7 and typically require re-insertion only 3 to 4 times per year. HTCA serves two end markets: men experiencing low testosterone and related symptoms (decreased libido, fatigue, weight gain, brain fog) and women experiencing perimenopause or menopause symptoms (hot flashes, night sweats, mood changes, decreased libido), with separate product lines for each segment.

The technology platform is a pellet-based drug delivery system rather than a software platform; the underlying intellectual property is the provider certification methodology, training curriculum, and the Purepell brand associated with the modality. Patient acquisition is content-led, using a wellness blog, gender-specific symptom quizzes, a provider store locator, and an active social media presence on Instagram and Facebook. There is no proprietary mobile app, no public API, and no AI components disclosed in the input data.

The business model is a B2B2C professional services network: HTCA recruits, trains, and certifies healthcare providers, who in turn deliver BHRT pellet treatments directly to patients and set treatment pricing. Revenue mechanics at the corporate level are not disclosed, but the model implies income from provider training, certification, and likely pellet product supply, while procedure fees flow to the individual providers. HTCA has 11-50 employees, was founded in 2014, and has not disclosed any funding rounds, acquisitions, or institutional investors.

Name

Hormone Therapy Centers of America

Legal name

Hormone Therapy Centers of America

Website

https://ht-ca.com

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

11–50 employees

Short description

Hormone Therapy Centers of America, operating as Purepell, runs a national network of Certified Purepell Providers that deliver bioidentical hormone replacement therapy via subcutaneous pellet implants. It serves men and women with age-related hormone imbalance and recruits and trains healthcare providers.

Ownership category

akta.pro rank

Headquarters

HQ city

Plano

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Healthcare Services: Purepell generates revenue through a network of Certified Purepell Providers who deliver bioidentical hormone replacement therapy treatments to patients. Treatments are tailored to individual patients and their specific needs, suggesting a service-based revenue model.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Hormone Therapy Centers of America delivers bioidentical hormone replacement therapy (BHRT) to men and women experiencing age-related hormone imbalance, primarily through subcutaneous pellet insertion that provides continuous hormone release. Services are rendered through a national network of Certified Purepell Providers, with patients directed to providers via the company's website, store locator, and symptom quizzes. The company also trains and certifies healthcare providers to administer pellet-based BHRT.

Product overview

Purepell (Hormone Therapy Centers of America) offers a unified bioidentical hormone replacement therapy (BHRT) platform centered on pellet therapy delivery. The core products include pellet therapy for both men and women, along with broader hormone therapy programs. Pellet therapy is positioned as the preferred delivery method over creams, patches, and injections, providing continuous 24/7 hormone release. The company also provides provider training and certification programs for healthcare professionals who wish to offer these services. Treatments are tailored to individual patients based on their symptoms and health history.

Differentiator

Problem solved

Functional benefit

Brands

• Purepell: Bioidentical Hormone Replacement Therapy brand offering pellet therapy for men and women

Products and services

• Bioidentical Hormone Replacement Therapy (BHRT) BHRT is a treatment designed to restore hormone levels to their optimal state, offering relief from symptoms associated with aging and hormone imbalance in men and women. Delivered through Purepell's Certified Provider network.
• Pellet Therapy Hormone pellets implanted under the skin provide dynamic, continuous 24/7 release of bioidentical hormones. Most patients require new pellets 3 to 4 times per year depending on activity level.
• Men's Hormone Therapy Hormone therapy services tailored for men, addressing symptoms of hormone imbalance including low testosterone, reduced libido, fatigue, brain fog, and weight gain.
• Women's Hormone Therapy Hormone therapy services tailored for women, addressing symptoms of menopause and perimenopause including hot flashes, night sweats, decreased libido, fatigue, and mood changes.
• Low T Treatment Treatment specifically targeting low testosterone (Low T) in men, addressing symptoms such as lethargy, brain fog, anxiety, low sex drive, and weight gain through pellet-based BHRT.
• Provider Training Program Training program for healthcare providers to become Certified Purepell Providers, enabling them to offer bioidentical hormone replacement therapy and pellet therapy to their patients. Includes certification and ongoing support.

Quantifiable outcome

• Most patients only require new pellets 3 to 4 times per year

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Scale indicators1 record

Recent moves4 records

Expansion highlights3 records

Emerging players

• Marek Health: Marek Health is a telehealth-focused men's hormone optimization and TRT provider, targeting the same low-T patient persona as Purepell but using a digital-first delivery model rather than in-clinic pellets. Partial overlap and an emerging competitive threat.
• AgelessRx: AgelessRx is a telehealth anti-aging and hormone optimization clinic offering TRT and related therapies to a similar age-related hormone decline patient base. Comparable patient overlap with Purepell but distinct digital delivery model.
• Evernow: Evernow is a digital women's health platform specializing in perimenopause and menopause treatment, including hormone therapy. Comparable to Purepell in addressing the same female hormone-decline use case, but through a subscription telehealth model.
• Winona: Winona is a telehealth menopause care provider offering hormone therapy to women. Comparable to Purepell on the women's perimenopause/menopause segment, though delivered virtually via prescriptions rather than pellets.

Direct peers

• BodyLogicMD: BodyLogicMD operates a nationwide network of physicians specializing in BHRT and integrative hormone therapy for men and women. Directly comparable to Purepell in target patients, services offered, and franchise-like provider model.
• BioTE Medical: BioTE Medical is the largest direct competitor in BHRT pellet therapy, operating a national network of certified providers trained to deliver subcutaneous hormone pellets. Highly comparable to HTCA's Purepell network in product, delivery mechanism, GTM, and target patient population.
• SottoPelle: SottoPelle is a pioneer in subcutaneous hormone pellet therapy, training and certifying providers across the U.S. Direct competitor to Purepell with overlapping product, patient demographic, and provider-network business model.
• Defy Medical: Defy Medical provides hormone replacement therapy, including testosterone and pellets, via telehealth and in-person clinics. Comparable to Purepell in addressing the same age-related hormone decline use cases for men and women.
• Evexias Health Solutions: Evexias trains and certifies medical providers in bioidentical hormone replacement therapy, including pellet-based protocols, and runs its own clinics. Comparable to Purepell in BHRT training-and-certification model and direct-to-patient hormone therapy services.

Broad incumbents

• Hims & Hers Health: Hims & Hers is a large, publicly traded telehealth platform that has expanded into testosterone and hormone-related treatments. Same patient demographic as Purepell, but broader portfolio, larger scale, and different (online, no pellets) delivery mechanism.

Market position

Strengths5 records

Weaknesses2 records

Competitive moat4 records

Key risks2 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/HTCAPellets
• Instagraminstagram.com/htcapellettherapy
• Xx.com/HTCAPELLETS
• LinkedInlinkedin.com/company/hormone-therapy-centers-of-america

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hormone Therapy Centers of America